QA: Globestar Therapeutics Corp in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2014_Globestar_Therapeutics_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001502152, Globestar Therapeutics Corp

  xvar xval
0 AssetsCurrent 138,206
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 324,352
4 LiabilitiesCurrent 121,058
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 96,218
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 555,132
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 448,340
11 remainder_Revenues 57,361
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 462,558
1 Liabilities 217,276
2 Expenses 1,003,472
3 Revenues 57,361
4 StockholdersEquity 245,282
5 NetIncome -946,111
6 ComprehensiveNetIncome -946,111
7 BaseVar 870,334
8 EconomicCapitalRatiobeforeLimitedLiability -1.21
9 EconomicCapitalRatio 1.25

Edgar->Model Mapping

Feature Distribution

Change over Time